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Abstract: During the last fours years a consortium of universities, hospitals and 
commercial companies has been working together for the development of 
innovative systems and services for mobile health care. Two major projects 
were financed by the European Union allowed us to develop a complete mobile 
healthcare system and validate it with extensive medical trials. MobiHealth1 
and HealthService241 have developed a generic Body Area Network (BAN) for 
healthcare and an m-health service platform. Biosignals measured by sensors 
connected to the BAN are transmitted to a remote healthcare location over 
public wireless networks (GPRS/UMTS), where doctors can monitor, diagnose 
and provide advice to patients in real time. The developed system is in the last 
phases of the pre-commercial validation and a commercial product is expected 
to be available in late 2006. 
1. Introduction 
Today the health sector faces serious and increasing problems in the management of 
resources for disease prevention, follow-up and remote assistance of patients. The 
cost of in-patient care is increasingly creating problems for both patients and social 
security organizations, while out of hospital monitoring of the patients’ health state is 
practically non-existent. The patient has either to measure different vital constants at 
regular intervals or has to visit the hospital. As a result, patients who need monitoring 
but are not at immediate risk are obliged to stay for long periods in hospital so that 
regular measurements can be taken. These results in high costs for the hospitals and 
health insurers, lost working hours and low morale of the patient.  
On the other hand, citizens are becoming more health conscious and are 
demanding advanced health services, as can be seen from the ever expanding para-
health market, where health related services are becoming increasingly common and 
available to every citizen. In the last few years for example services and applications, 
                                                          
1 This work was supported by the Commission of the European Union in the 5th research 
Framework under the MobiHelath project (IST-2001-36006) and in the eTen program under 
the HealthService24 project (C517352) Project sites http://www.mobihealth.org and 
http://www.heathservice24.com 
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such as physical state monitoring during sports training and the use of health call 
centres and on-line health consultations have been commercialized in almost all 
European countries.  
Finally, citizen mobility at a pan-European level is increasing, with thousands of 
citizens crossing European country borders daily for purposes of entertainment, 
leisure, shopping and business. This mobility is strongly supported by the widely 
available communication services, like mobile telephony and mobile internet access, 
available today in the most remote points of the European continent (and the globe!). 
One of the major technological advances of the 21st century will be the 
implementation and wide availability of public broadband wireless networks, and 
specifically 3G (UMTS) and 4G networks.  
The above described needs of the citizens and patients combined with the 
evolution and availability of wireless communication networks and the ever-
advancing miniaturization of sensor devices and computers, will give rise to new 
services and applications that will have a major effect in health care. Citizens, being 
patients or non-patients, will not only be able to get medical advice from a distance 
but will also be able to send from any location full, detailed and accurate vital signal 
measurements, as if they had been taken to a medical center, implementing the  
“ubiquitous medical care” dream. 
Towards this direction we have completed a research project and are running a 
commercial validation project, for the development and deployment of innovative 
value-added mobile health services, based on 2.5 (GPRS) and 3G (UMTS) networks.  
The MobiHealth research project (financed by the European Union under the IST 
programme (IST-2001-36006)), started in May 2002 and completed in February 2004, 
developed a technically validated and fully functioning mobile platform and solution 
for ambulant patient monitoring with measurements transmitted over public wireless 
networks. This was achieved with the integration of sensors in a wireless Body Area 
Network (BAN). The BAN connected sensors continuously measure and transmit 
vital constants to health service providers or health brokers. This way the BAN 
facilitates remote monitoring of patients’ vital signs and therefore enables proactive 
disease prevention and management by continuous monitoring of patients’ health 
condition ‘anytime and anywhere’.  
With the completion of the research project and the very encouraging results and 
comments coming from the system users (hospitals and patients) we proceeded 
towards the first phase of the commercialisation of the system and services. A new 
18th months project, HealthService24, under the eTen framework was launched in 
February 2005, with the goal of to validating the existing service in the market in 
order to have a fully marketable solution at the end of the project. The solution will be 
validated and fine-tuned to the extent that will enable a sustainable market 
deployment at the end of the market validation phase. 
1.1 Overview of the projects’ results and targets 
The use of health BANs together with advanced wireless communications enables 
remote management of chronic conditions and detection of health emergencies whilst 
maximising patient mobility. MobiHealth has developed a generic BAN for 
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healthcare and an m-health service platform. The BAN incorporates a set of body-
worn devices and handles wireless communication (via Bluetooth) amongst those 
devices. It also handles external communication (via GPRS/UMTS) with a remote 
location. The main devices used in the project are medical sensors like 3 to 7 lead 
ECG/EMG, respiration belts and oxygen saturation sensors. The remote healthcare 
location is a healthcare provider (a hospital or medical call centre). Biosignals 
measured by sensors connected to the BAN are transmitted to the remote healthcare 
location over wireless telephony services.  
The results of the project include an architecture for, and a prototype of, a generic 
service platform for provision of ubiquitous healthcare services based on wireless 
Body Area Networks. The MobiHealth BAN and service platform were trialled in 
four European countries with a variety of patient groups. The MobiHealth system can 
support not only sensors, but potentially any body worn devices, hence the system has 
potentially very many applications in healthcare which allow healthcare services to 
delivered in the community. In the last months of the project 9 different trials 
scenarios were implemented for different patient groups. These trials allowed us to 
identify problems and issues in the development of m-health services and to identify 
limitations and shortcomings of the existing and forthcoming public network 
infrastructures. 
The HealthService24 project was started in February 2005 and will be completed 
in July 2006. The main objective of HealthService24 is to test the feasibility of the 
deployment of the mobile healthcare services via trials that will validate the precise 
conditions to be fulfilled for the subsequent deployment of the services.  
In HealthService24 three trial scenarios at different sites in Europe are used for the 
validation of the deployment conditions. It should be noted that an important part of 
the project is the introduction of the required adaptations in order to correct problems 
that were identified in the trials of the MobiHealth project. 
2. The MobiHealth System and Services  
MobiHealth has developed a mobile health BAN and a generic service platform for 
BAN services for patients and health professionals. Remote patient monitoring is only 
one of the kinds of services that can be provided.  
The healthcare BAN is an innovative health monitoring tool that incorporates a 
range of devices including sensors and actuators, together with communication and 
processing capabilities. Communication between entities within a BAN is called 
intra-BAN communication. To use the BAN for remote monitoring, external 
communication is required which is called extra-BAN communication. The gateway 
that facilitates extra-BAN communication is the Mobile Base Unit (MBU). 
The MobiHealth system provides a complete end-to-end e-health platform for 
ambulant patient monitoring, deployed over UMTS and GPRS networks. The 
MobiHealth patient/user is equipped with different vital constant sensors, like blood 
pressure, pulse rate and ECG interconnected via the healthcare Body Area Network 
(BAN). The Mobile Base Unit (MBU) is the central point of the healthcare BAN, 
acting as a gateway aggregating the vital sensor measurements (intra-BAN 
communication based on wireless networks like Bluetooth[1] and Zigbee[2]) and 
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transmitting them to the back-end system (extra-BAN communication based on GPRS 
and UMTS), which may be located within the health broker premises or may be 
located at the wireless services provider’s site. From there the measurements are 
dispatched to the health care provider or broker where the medical personnel monitor 
them life or store them for automatic processing. Figure 1 shows the architecture of a 
BAN. Sensors and actuators establish an ad-hoc network and use the MBU to 
communicate outside the BAN. The MBU can be any device with sufficient 
processing power able to manage the BAN and provide extra-BAN communication 
services. 
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Figure 1 : BAN architecture 
2.1 The MobiHealth Body Area Network 
The concept of the Body Area Network originally came from IBM[3] and was 
developed further by many other researchers, for example at Philips [4], at the 
University of Twente [5], and at Fraunhofer [6]. In the Wireless World Research 
Forum’s Book of Visions, we define a BAN as “a collection of (inter) communicating 
devices which are worn on the body, providing an integrated set of personalised 
services to the user”[11].  
In the context of the MobiHealth project the Healthcare BAN is a health 
monitoring tool that consists of sensors, actuators, communication and processing 
facilities connected via a wireless network which is worn on the body and which 
moves around with the person (i.e., the BAN is the unit of roaming). A sensor is 
responsible for the data acquisition process, ensuring that a physical phenomenon, 
such as patient movement, muscle activity or blood flow, is first converted to an 
electrical signal, which is then amplified, conditioned, digitised and communicated 
within the BAN. 
The Healthcare BAN sensors can be self-supporting and/or front-end supported. 
Self-supporting sensors have a power supply and facilities for amplification, 
conditioning, digitisation and communication. Self-supporting sensors are 
independent building blocks of a BAN and ensure a highly configurable healthcare 
BAN. However, each sensor runs at its own internal clock and may have a different 
sampling frequency. Consequently, mechanisms for the synchronization between 
sensors may be needed. 
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Front-end supported sensors share a common power supply and data acquisition 
facilities. Consequently, front-end supported sensors typically operate on the same 
front-end clock and jointly provide multiplexed sensor samples as a single data block. 
This avoids the need for synchronization between sensors. 
A sensor is responsible for the data acquisition process, ensuring that a physical 
phenomenon, such as patient movement, muscle activity or blood flow, is first 
converted to an electrical signal. This signal is then amplified, conditioned, digitised 
and communicated inside the BAN. 
2.2 Service platform architecture 
Collecting and transmitting the vital signal measurements is only part of the 
healthcare service platform developed in the MobiHealth project and shown in Figure 
2. The dotted square boxes indicate the physical location where parts of the service 
platform are executing. The rounded boxes represent the functional layers of the 
architecture. The M-health service platform consists of sensor and actuator services, 
intra-BAN and extra-BAN communication providers and an M-health service layer. 
The M-health service layer integrates and adds value to the intra-BAN and extra-BAN 
communication providers masking applications from specific characteristics of the 
underlying communication providers. 
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Figure 2 Service platform functional architecture 
 
Applications that run on top of the service platform can either be deployed on the 
MBU (for on-site use e.g. by a visiting nurse) or on the servers or workstations of the 
healthcare provider, i.e. the call centre or the co-located secondary care centre in 
Figure 2. For this the M-health service platform offers a number of services including: 
 
o BAN registration: the service platform maintains a list of active BANs and allows 
applications to retrieve the specific configuration of a BAN.  
o BAN discovery: applications can subscribe to the platform to receive a 
notification in case a BAN becomes active (i.e. a patient switches on a BAN). 
o BAN authorization and authentication: the service platform authenticates BANs 
and only allows authorized BANs to convey data.  
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o BAN data encryption: the platform encrypts data that is conveyed over unsecured 
networks 
o BAN configuration: the service platform allows online configuration and 
management of the BANs, such as (de)activation of specific sensors or 
modification of the sample frequency of a sensor. 
o Data acquisition control: the service platform enables applications to start, stop 
or temporarily interrupt the data acquisition process of a BAN. 
o Query and modify actuator status: applications can manipulate actuators from a 
distance. 
o BAN data storage: the service platform can act as an intermediate storage 
provider to applications. Applications determine the minimal duration of the 
storage. 
o BAN data monitoring: the service platform can apply filtering algorithms on the 
BAN data to determine if an interesting event has taken place (e.g. a patient has 
dropped on the floor) and report this event to the application layer.  
2.3 Service platform technical requirements 
To leverage the healthcare BAN for use as a remote monitoring tool several issues 
and considerations were taken into account in the design and development of the 
supporting healthcare service platform. These issues reflect both, commercial and 
social needs or restrictions, as well as technical limitations of underlying [8]. The 
most important ones being scalability, security and extra-Ban network restrictions. 
Scalability: The healthcare service platform must be able to support services that 
cover niche healthcare cases that require the simultaneous monitoring of small 
numbers of patients (e.g., ranging from 10 to 100 BANs) to large-scale chronic 
disease management processes (e.g., 100.000+ BANs used to monitor COPD 
patients). In addition geographical scalability, that is global coverage, should be 
supported. 
Security. The healthcare service platform connects the BAN with the Internet. 
Consequently, the BAN is potentially vulnerable to attacks from malicious Internet 
users who may either try to break into the system or frustrate its use. Therefore the 
healthcare service platform should be protected from attacks like Denial of Service 
(DoS). Mechanisms that ensure data integrity must be included to prevent corruption 
of BAN data. Each BAN should authenticate itself with the service platform, which 
should only allow authorized BANs to send BAN data (i.e. preventing masquerading) 
and access controls are needed to prevent unauthorised access to BAN control signals 
and/or data. 
Mask ‘inverted-producer-consumer’ problem. Traditionally, providers of data 
(such as web servers) are deployed on a computing infrastructure with sufficient 
network and processing capacity. Consumers of data (such as web browsers) assume 
that providers are available most of the time (except for maintenance) and have 
sufficient bandwidth to serve a reasonable number of consumers. This model was the 
one adopted by the public wireless network operators where the data consumer, i.e., 
the mobile device, initiates a network connection to the producer. Based on this 
assumption, most network operators of 2.5/3G networks hand out private space IP 
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addresses to mobile devices. Connection establishment initiated from a fixed host on 
the public Internet to a mobile device is therefore inhibited.  
However in the MobiHealth system each BAN is a data producer. For the service 
platform, the producer and consumer roles are thus inverted because the provider of 
data is deployed on a mobile device (i.e. the MBU) while the consumer of data is 
deployed on a fixed host with sufficient processing and communication capacity. The 
MBU may be temporary unavailable, due to the short life-time of batteries or because 
it has moved to an area without coverage of the public wireless infrastructure. The 
service platform therefore masks the inversion of the producer-consumer roles from 
the BAN and the end-users (e.g., a patient wearing the BAN or a medical specialist 
analyzing the BAN data). 
2.4 The MobiHealth Trials 
The MobiHealth system and services were validated with a number of trials that 
spanned four European countries and covered a range of conditions including 
pregnancy, trauma, cardiology, rheumatoid arthritis and respiratory insufficiency and 
made use of patient BANs and health professional BANs (nurse BAN, paramedic 
BAN). The trials were selected to represent a range of bandwidth requirements: low 
(less than 12 Kbps), medium (12 – 24 Kbps) and high (greater than 24 Kbps) and to 
include both non-real time (e.g. routine transmission of tri-weekly ECG) and real time 
requirements (e.g. alarms, transmission of vital signs in a critical trauma situation). 
For each application the generic MobiHealth BAN was specialized by addition of the 
appropriate sensor set and corresponding application software. The nine trials were : 
Trial 1 - Germany : Telemonitoring of patients with cardiac arrhythmia 
Trial 2 - The Netherlands: Integrated homecare for women with high-risk pregnancies 
Trial 3 - The Netherlands : Tele trauma team  
Trial 4 - Spain: Support of home-based healthcare services 
Trial 5 - Spain : Outdoor patient rehabilitation 
Trial 6 - Sweden : Lighthouse alarm and locator trial 
Trial 7 - Sweden : Physical activity and impediments to activity for women with RA 
Trial 8 - Sweden: Monitoring of vital parameters in patients with respiratory 
insufficiency 
Trial 9 - Sweden : Home care and remote consultation for recently released patients in 
a rural area 
3. Results of the MobiHealth project 
The MobiHealth project was completed successfully in February 2004 and a series of 
important results were obtained. First of all the project developed an architecture for, 
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and a prototype of, a generic service platform for the provision of ubiquitous 
healthcare services based on wireless Body Area Networks and 2.5/3G networks. The 
developed system was used to validate the ability of the commercially available 
2.5/3G networks to support advanced mobile health services. The performed trials 
allowed us to identify the usefulness and the user acceptance of the services in 
different medical specialties, as well as the problems and issues that need to be 
resolved for its deployment. Finally the project trials allowed us to identify the market 
considerations and the different actors that need to be involved in a commercial 
deployment.  
During the trials different types of data were collected by the evaluation team 
responsible for evaluation of the results. The trials were evaluated using a 
methodology developed in the project. Specifically we evaluated the trials from the 
technical point of view (technical evaluation), the medical point of view (end-user and 
social evaluation) and from the business point of view (market evaluation). 
The technical evaluation focused on the evaluation of the performance of the 
communication infrastructure characterized in terms of: availability, bandwidth 
characteristics, percentage of data loss/corruption, transmission delay and its variation 
(“jitter”). In addition to the network performance the technical evaluation also 
assessed the overall system in terms of validity, accuracy and robustness of the Sensor 
Service and application, the BAN and the intra-BAN communications, time delays 
etc. 
The system performance related parameters were logged at the BAN side, while 
the generated traffic was logged by the 2.5/3G network measurement system. Logs at 
the BAN side record any problems regarding access to the network and the process of 
transmitting the data to the BEsys. The network log reports were used to verify if any 
of the logged problems at the BAN side could have been caused by the current status 
of the network during that time.  
The performance characteristics of the MobiHealth communication infrastructure 
were derived in two ways: objective and subjective evaluation.  
The objective evaluation of the infrastructure included active and passive 
measurements. For the active measurements an external data stream was generated 
(that is, we had no real MobiHealth data) and the performance characteristics of the 
communication paths were measured. The passive measurements were performed in 
the up-and-running MobiHealth system so that real MobiHealth data were used. 
During the passive measurement phase, the participating operators also performed 
core-network data logging of the MobiHealth traffic characteristics [10]. 
The subjective evaluation of the infrastructure’s performance was done by the 
end-users (healthcare professionals) who expressed their perceptions of functionality 
and performance characteristics as experienced during the usage of the MobiHealth 
system.  
Part of the technical evaluation was the 2.5/3G Network Evaluation. The 
analysis of the network performance evaluation data collected during the trials 
provides interesting results regarding the performance of the UMTS networks and 
technical issues related to MobiHealth BAN. Although the current UMTS networks 
are stable and functional, there are many barriers and technological details that need 
to be resolved before stable and viable m-health services can be introduced into the 
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market. Some of the most important problems are the restricted available data 
bandwidth for uplinks, delay variation, delays in transmission and handovers. 
The end user evaluation described the usability/acceptance of the MobiHealth 
Services seeking the subjective opinion of users regarding the new services, their 
usability, user interaction, satisfaction, suitability, usefulness, acceptance, 
independence and experiences. Also questions about perceived performance 
characteristics of the system, like: system accuracy, validity, robustness, its speed or 
availability of the service were addressed to the professional users. End users in this 
project were defined as the patients and the health care personnel who were involved 
in the trials and were using the MobiHealth system. 
The end-user evaluation data were collected using diaries, questionnaires, 
interviews and some objective measurements, e.g. walking distance and step-length 
for mobility assessment. End-users’ evaluation results were compared against the 
performance measurements of the platform to analyse existence of expected 
correlations. An example of correlation between user experience and measured 
technical performance would be the receipt of an unusable poor quality ECG, which 
cannot be interpreted by the professional, coinciding with large delays and packet 
drops in the system indicating communication throughput problems. 
The goal of the market evaluation was to provide a set of criteria which would 
allow valid statements and decisions regarding the market value and potential of the 
MobiHealth system in the respective trial settings to be made. The factors which were 
important and decisive in this context included: health political issues, existing market 
structures and processes, market players, business scenarios, value chains, potential 
users, users’ characterization (behaviour, acceptance requirements), health economic 
relevance, realization of market potentials (how much and when), barriers of entry, 
opportunities and threats.  
4. Towards commercialization : The HealthService24 project 
One of the results of the MobiHealth project was the validation of the fact that today 
there is no concise mobile monitoring service available in Europe. There are various 
systems, services and applications available, which allow users to monitor their health 
status and transmit some type of vital signal information to remotely located medical 
personnel, e.g. pregnant women can be monitored from home, instead of being 
admitted to the hospital, Rheumatoid Arthritis patients can be monitored remotely 
during rehabilitation exercises at home, the glucose level can be registered and the 
patient can download the data once a day/week to a PC and send it to the hospital. 
However, the currently available services allow patients to monitor and transmit their 
state over a wired phone (home services), meaning that the mobility of users is very 
limited, as they need a telephone line and electricity connection. The medical tools 
available today are only on the level of administrative information (the doctor has a 
PDA with which he can access the medical record of the patient and send information 
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using GSM/GPRS). The mobile solutions that start appearing in the market either are 
simple technological solutions with no complete integrated service to support them or 
at best they simply provide the possibility for the patient to store the vital signal 
measurements and upload them at the evening to the hospital server. 
HealthService24 aims to bridge this gap by offering a viable mobile health care 
service permitting healthcare professionals to remotely assess, diagnose and treat 
patients whilst the patients are free to continue with daily life activities. The 
HealthService24 services will allow patients and non-patients to monitor their 
physical condition and obtain advice and information at any place and moment. 
Hence the service will enable patients to be fully mobile.  The starting point is the 
system developed and validated during by the MobiHealth project.  
Being aware of the fact that many former technological innovations in the field of 
mobile health applications were not successful in the longer run due to failure to 
address crucial issues such as social and economic aspects, changes in medical work 
practices and even standardization of technologies and integration with existing 
medical information systems, the HealthService24 project will be dealing with the 
adaptation, customization and localization of the existing service prototype, the 
related social aspects and working conditions, and the related economic issues 
stemming from the deployment of the system on a larger scale, including the changes 
that will be brought to the processes and practices of the healthcare organizations and 
medical personnel. The HealthService24 will define the needs, expectations and 
requirements of all members of the value chain and will create added value and 
benefits for all value chain members, as only such an approach can make a sustainable 
market deployment possible. We aim to have a commercial product at the end of the 
project (Fall 2006).  
4.1 The HealthService24 operation scenario 
A HealthService24 patient/user is equipped with variety of vital constant sensors, like 
blood pressure, pulse plethismogram and ECG interconnected in a wireless Body 
Area Network managed by a PDA or mobile telephone and worn on the body, and 
thus moving around with the person. These way patients can stay mobile but be 
continuously monitored and receive advice when needed. 
The measurements are transmitted wirelessly using UMTS (or GPRS) to a data 
centre acting as an intermediary between patients/users and health care providers and  
providing three services: data repository (just collecting of the received data), 
streaming service (forwarding data to a doctor), and alarming service (interpretation 
of the received data and sending of an alarm signal to a predefined destination (using 
SMS)). The data centre may also provide technical support and, if needed, act as the 
first-level medical support for the HealthService24 users.  
From the data centre the data is wirelessly transferred to health care providers.  
Data sent to a health care provider can be viewed (e.g. on a laptop).  Healthcare 
professionals, to whom the patients’ data is transferred, can remotely assess, diagnose 
and treat patients whilst the patients stay fully mobile and continue with their daily 
life activities. 
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4.2 Validation trials 
In order to test and verify the system, the service and the network infrastructure for its 
suitability and the restrictions it imposes on mobile health care applications, nine 
validation trials will be conducted within the project in three different countries in 
Europe: Netherlands, Spain and Cyprus. Three different groups of patients will test 
the service: (high-risk) pregnant women, cardiac patients and COPD-patients 
(Chronic Obstructive Pulmonary Disease) with respiratory problems. The (high-risk) 
pregnant women trials will be carried out in Netherlands, the COPD-patients trials in 
Spain, and the cardiac patients trials in Cyprus.  
It is envisaged to conduct three validation trials at each test side. Each trial will 
last approx. 3 months followed by 1 month results analysis. As the market validation 
is an interactive process, the results obtained during the first set of trials will be fed 
into the next phases. Each set of trials will be carried out by a hospital/clinic 
specialised in the particular disease/health problem to guarantee the highest possible 
quality level and credibility of the results. 
As the number of patients/ users needed per group for a validation trial varies 
depending on the expected hospital days, different numbers of patients need to be 
validated within each group. Taking the above into consideration and to assure 
reliable results from the validation trials, a minimum of 8 pregnant women per trial 
shall be monitored and 15 COPD- and cardiac patients, which means that in all three 
trials per patient group at least 25 (high-risk) pregnant women, 45 COPD-patients and 
45 cardiac-patients will be monitored.  
For the (high-risk) pregnant women trials, the trials will use the HealthService24 
to support integrated homecare for women with high-risk pregnancies. Women with 
high-risk pregnancies are often admitted to the hospital for longer periods of time 
because of possible pregnancy-related complications. Admission is necessary for the 
intensive monitoring of the patient and the unborn child. Homecare with continuous 
monitoring is desirable and can postpone hospitalisation and reduce costs, as well as 
offering more security for the mother and unborn child. In this trial, patients will be 
monitored using the patient-BAN. The maternal and foetal bio-signals will be 
remotely transmitted to the hospital. An additional objective of the trial will be to 
evaluate if such a solution postpones hospitalisation and reduces costs. This trial takes 
place in Enschede, the Netherlands in the Medisch Spectrum Twente Hospital. 
For the COPD-patients trials, the trials will use the HealthService24 to support 
remote assistance for elderly and chronically ill patients suffering from co-morbidities 
including the COPD. The MobiHealth nurse-BAN will be used to perform patient 
measurements during nurse home visits and the MobiHealth patient-BAN will be used 
for continuous monitoring during patient rehabilitation at home or outdoors. It is very 
important to facilitate patients' access to healthcare professionals without saturating 
the available resources, and this is one of the main expected outcomes of the 
HealthService24 remote monitoring approach. Parameters to be measured are oxygen 
saturation, ECG, spirometry, temperature, glucose and blood pressure. The trials take 
place in the Barcelona, Spain, at the Hospital Clínic i Provincial de Barcelona. 
For the cardiac patients trials, the HealthService24 will be tested by two groups 
of patients:  
12      Dimitri Konstantas, Richard Bults, Aart Van Halteren, Katarzyna Wac, Val Jones, 
Ing Widya, Rainer Herzog, Barbara Streimelweger 
Group1: Patients who had an acute episode and have been admitted and stabilised 
but need continuing monitoring of condition and drug regime for a further few days. 
With the HealthService24 these patients will  be allowed an earlier discharge,  with an 
appropriate follow up (using the HealthService24) in the place of their choice. 
Group 2: Patients in a suspected acute episode, brought in for examination; a 
decision needs to be taken whether to keep the patients at the hospital for observation, 
or to discharge them home. In case a patient is discharged, and there is a suspicion of 
an abnormal condition, the patient will be equipped with the MobiHealth patient-
BAN enabling constant monitoring of the patient’s state. 
The cardiac patients’ trial takes place in Agia Napa, Cyprus, at the LITO Polyclinic. 
4.3 Evaluation procedure 
Metrics for evaluating the test results will include general indicators such as quality of 
life (and care) for both patient and doctor, economic benefits for a patient/government 
of not staying in hospital (and freeing a hospital bed), overall costs of the service and 
adaptation issues to adjust the service to national requirements as well as reliability, 
accuracy and sensitivity of the equipment and ease of use for patient and health 
professional. A number of questionnaires will be prepared, issued and evaluated. 
During the trials different types of data will be collected in view of an evaluation 
of the results. The targets of the evaluation include both technical and socio-economic 
aspects. From the technical side, the state of the UMTS (and GPRS) infrastructure and 
its suitability for mobile health applications will be verified, while from the socio-
economic side the added value that the HealthService24 can bring to different 
healthcare domains will be explored and the related issues for its commercial 
deployment will be evaluated. The technical issues have already been addressed by 
the MobiHealth project, so the HealthService24 project will mostly just confirm that 
results and concentrate on the health-economic and socio-economic aspects to make 
the service ready for the market deployment.   
4.4 Status of the HeathService24 project 
From the first days of the project we realized that the market is already mature and 
ready to accept the deployment of m-health services, as proposed by the HS24 
project. As a result the project objectives not only remain valid, but there is a need for 
a faster deployment in order to catch the present market opportunities. For this reason 
an adaptation of the time frame of the short and long term objectives was made and, 
furthermore Ericsson adapted its internal structure and processes in order to fulfil in a 
shorter time the objectives of the project. As a result we were forced to delay the start 
of the trials for 4 months and adapt the existing system, bringing it closer to a 
commercial product. Finally in September 2005 the trials were started with an adapted 
system that was stable with additional functionality and with a simple and ergonomic 
user interface as requested by the users. The system allows for example the 
prioritization of the signals to be sent, so in case of low bandwidth the least 
“important” signals are not sent to the hospital but stored locally, allows for off-line 
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operation in case of connectivity breakdown or for energy conservation, is able to 
store and retransmit historical data on request etc. Further secondary functionalities as 
well as administrative interfaces will be added to the system in the next few months. 
Some of the items that were added in the user interface were basic information 
regarding pulse rate and/or oxygen saturation as well as an easy to read indication (for 
the pregnancy trial) that labour is highly probable and the woman should come to the 
hospital at once. In addition and most importantly, simply explained information on 
the connectivity status. The user knows at any instance if he is connected and if not 
where is the problem (see Figure 31. Mobile user interface). 
 
 
  
Figure 31. Mobile user interface 
5. Conclusions 
The results of the project indicate that several issues need to be resolved by both 
network operators and hardware manufacturers for a better support to mobile health 
services [9]. Ambulatory monitoring is more successful for some biosignals than 
others, for example some measurements are severely disrupted by movement 
artefacts. Some monitoring equipment is still too cumbersome for ambulatory use, 
because of the nature of the equipment or because of power requirements (Powering 
always-on devices and continuous transmission will continue to raise technical 
challenges for the next decade for mobile applications!). Furthermore even with 2.5 
and 3G, we still suffer from limited bandwidth for applications that serve many 
simultaneous users.  
Other challenges relate to security, integrity and privacy of data during 
transmission to both local transmission (e.g. intra-BAN) and long range (e.g. extra-
BAN) communications. Legislation differences between European countries do create 
some problems in the adoption of mobile systems. Some harmonization is expected in 
the future but it will take time to become reality. 
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Business models for healthcare and accounting and billing models for network 
services need to evolve if technical innovations are to be exploited fully. 
Standardisation at all levels is essential for open solutions to prevail. At the same time 
specialization, customisation and personalisation are widely considered to be success 
criteria for innovative services.  
The main problems identified relating to the introduction of new mobile health 
services based on Internet technologies into hospitals relate to the changes required to 
support these new services, in both technological level and work practices level. From 
a technology point of view, the introduction of new mobile services requires a modern 
ICT infrastructure with secure connections to the Internet. However, many hospitals 
today do not have this kind of ICT infrastructure. Some hospital IT departments 
didn’t even accept the use of standard HTTPS (i.e. HTTP over secure sockets) to 
retrieve vital sign information. On the other hand other hospitals demanded that the 
mobile system fully integrates with their existing IT system, using the same data 
exchange standards and formats. 
A second technology related problem concerns the precaution measures taken by 
the majority of the hospitals in the use of wireless communication devices inside the 
hospitals. Due to lack of serious studies regarding the interference of wireless 
communication devices, like telephones, with medical equipment, most hospitals 
prohibit the use of any such device within their premises. This has as an immediate 
consequence that any wireless medical system will have difficulties to be officially 
authorised to function inside the hospital. 
Nevertheless, from the reactions and interest of the hospitals and the patients we 
are very optimistic that the proposed MobiHealth/HS24 system and services will be a 
commercial success. 
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